Gullik Håkan Wickholm
Director/Board Member bei Beactica Therapeutics AB
Profil
Gullik Håkan Wickholm is currently a Director at Beactica Therapeutics AB and GHW Consulting AB.
Previously, he served as the Chief Executive Officer at Lytix Biopharma AS from 2014 to 2017.
He also worked as the Head-Regional Business Development at AstraZeneca.
AS and as a Director at Genovis AB.
Wickholm received his undergraduate degree from the University of Uppsala.
Aktive Positionen von Gullik Håkan Wickholm
| Unternehmen | Position | Beginn |
|---|---|---|
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Director/Board Member | 01.01.2018 |
| GHW Consulting AB | Director/Board Member | - |
Ehemalige bekannte Positionen von Gullik Håkan Wickholm
| Unternehmen | Position | Ende |
|---|---|---|
| AstraZeneca AS | Corporate Officer/Principal | - |
| GENOVIS AB | Director/Board Member | - |
| LYTIX BIOPHARMA | Chief Executive Officer | 07.09.2017 |
Ausbildung von Gullik Håkan Wickholm
| University of Uppsala | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GENOVIS AB | Health Technology |
| LYTIX BIOPHARMA | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| AstraZeneca AS | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
| GHW Consulting AB |
